Literature DB >> 34117847

Effect of glutamine metabolism on chemoresistance and its mechanism in tumors.

Xinyang Hu1, Hongchuan Jin1, Liyuan Zhu1.   

Abstract

The metabolic reprogramming of tumor cells is characterized by increased uptake of various nutrients including glutamine. Glutamine metabolism provides the required substances for glycolysis and oxidative phosphorylation and affects the homeostasis of carbohydrate,fat and protein metabolism to induce the chemoresistance of tumor cells. Combination of chemotherapeutic agents with inhibitors specific to different components of glutamine metabolic pathway has obtained favorable clinical results on various tumors. Glutamine metabolic pathway plays a role in drug resistance of tumor cells in various ways. Firstly,the dynamic change of glutamine transporters can directly affect intracellular glutamine content thereby causing drug resistance; secondly,tumor stromal cells including adipocyte,fibroblast and metabolite from tumor microenvironment would give rise to immune-mediated drug resistance; thirdly,the expression and activity of key enzymes in glutamine metabolism also has a critical role in drug resistance of tumors. This article reviews the effects of glutamine metabolic pathway in the development of tumor chemoresistance,in terms of transporters,tumor microenvironment and metabolic enzymes,to provide insight for improving the therapeutic efficacy for drug-resistant tumors.

Entities:  

Keywords:  Cell metabolism; Drug resistance; Glutamine; Review; Tumor

Mesh:

Substances:

Year:  2021        PMID: 34117847      PMCID: PMC8675065          DOI: 10.3724/zdxbyxb-2021-0040

Source DB:  PubMed          Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban        ISSN: 1008-9292


  49 in total

Review 1.  Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms.

Authors:  Eugenia E Calle; Rudolf Kaaks
Journal:  Nat Rev Cancer       Date:  2004-08       Impact factor: 60.716

Review 2.  Glutamine and cancer: cell biology, physiology, and clinical opportunities.

Authors:  Christopher T Hensley; Ajla T Wasti; Ralph J DeBerardinis
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

3.  Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment.

Authors:  Kazuhiro Tanaka; Takashi Sasayama; Yasuhiro Irino; Kumi Takata; Hiroaki Nagashima; Naoko Satoh; Katsusuke Kyotani; Takashi Mizowaki; Taichiro Imahori; Yasuo Ejima; Kenta Masui; Beatrice Gini; Huijun Yang; Kohkichi Hosoda; Ryohei Sasaki; Paul S Mischel; Eiji Kohmura
Journal:  J Clin Invest       Date:  2015-03-23       Impact factor: 14.808

Review 4.  Understanding the Warburg effect: the metabolic requirements of cell proliferation.

Authors:  Matthew G Vander Heiden; Lewis C Cantley; Craig B Thompson
Journal:  Science       Date:  2009-05-22       Impact factor: 47.728

5.  A Variant of SLC1A5 Is a Mitochondrial Glutamine Transporter for Metabolic Reprogramming in Cancer Cells.

Authors:  Hee Chan Yoo; Seung Joon Park; Miso Nam; Juwon Kang; Kibum Kim; Joo Hye Yeo; Joon-Ki Kim; Yunkyung Heo; Hee Seung Lee; Myeong Youl Lee; Chang Woo Lee; Jong Soon Kang; Yun-Hee Kim; Jinu Lee; Junjeong Choi; Geum-Sook Hwang; Seungmin Bang; Jung Min Han
Journal:  Cell Metab       Date:  2019-12-19       Impact factor: 27.287

Review 6.  Altered glutamine metabolism and therapeutic opportunities for lung cancer.

Authors:  Amr Mohamed; Xingming Deng; Fadlo R Khuri; Taofeek K Owonikoko
Journal:  Clin Lung Cancer       Date:  2013-11-13       Impact factor: 4.785

Review 7.  Targeting Metabolic Plasticity and Flexibility Dynamics for Cancer Therapy.

Authors:  Sarah-Maria Fendt; Christian Frezza; Ayelet Erez
Journal:  Cancer Discov       Date:  2020-11-02       Impact factor: 38.272

8.  MYC regulates the unfolded protein response and glucose and glutamine uptake in endocrine resistant breast cancer.

Authors:  Ayesha N Shajahan-Haq; Katherine L Cook; Jessica L Schwartz-Roberts; Ahreej E Eltayeb; Diane M Demas; Anni M Warri; Caroline O B Facey; Leena A Hilakivi-Clarke; Robert Clarke
Journal:  Mol Cancer       Date:  2014-10-23       Impact factor: 27.401

9.  Regulation of stem-like cancer cells by glutamine through β-catenin pathway mediated by redox signaling.

Authors:  Jianwei Liao; Pan-Pan Liu; Guoxin Hou; Jiajia Shao; Jing Yang; Kaiyan Liu; Wenhua Lu; Shijun Wen; Yumin Hu; Peng Huang
Journal:  Mol Cancer       Date:  2017-02-28       Impact factor: 27.401

Review 10.  Epitranscriptomics and epiproteomics in cancer drug resistance: therapeutic implications.

Authors:  Huibin Song; Dongcheng Liu; Shaowei Dong; Leli Zeng; Zhuoxun Wu; Pan Zhao; Litu Zhang; Zhe-Sheng Chen; Chang Zou
Journal:  Signal Transduct Target Ther       Date:  2020-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.